Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?

about

Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?

Item

http://www.wikidata.org/entity/Q47669409

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@en

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@nl

type

Item

label

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@en

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@nl

prefLabel

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@en

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@nl

P1476

Discrepant HPV/cytology cotest ...... cal intraepithelial neoplasia?

@en

P2093

Antoinette D Davis

http://www.w3.org/2001/XMLSchema#string

Danielle N Fasciano

http://www.w3.org/2001/XMLSchema#string

Isam-Eldin A Eltoum

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Declining death rates reflect progress against cancer.

No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients.

p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.

Evaluating HPV-negative CIN2+ in the ATHENA trial.

The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

P304

795-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCY.21905

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Jessica M Tracht

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28817235

http://www.w3.org/2001/XMLSchema#string